Cargando…

Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders

The number of children with mild neurodevelopmental disorders, such as autism, has been recently increasing in advanced countries. This increase is probably caused by environmental factors rather than genetic factors, because it is unlikely that genetic mutation rates suddenly increased within a sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Takeo, Takae, Hirasawa, Miyake, Kunio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763642/
https://www.ncbi.nlm.nih.gov/pubmed/24281407
http://dx.doi.org/10.3390/ph5040369
_version_ 1782283051403837440
author Kubota, Takeo
Takae, Hirasawa
Miyake, Kunio
author_facet Kubota, Takeo
Takae, Hirasawa
Miyake, Kunio
author_sort Kubota, Takeo
collection PubMed
description The number of children with mild neurodevelopmental disorders, such as autism, has been recently increasing in advanced countries. This increase is probably caused by environmental factors rather than genetic factors, because it is unlikely that genetic mutation rates suddenly increased within a short period. Epigenetics is a mechanism that regulates gene expression, depending not on the underlying DNA sequence but on the chemical modifications of DNA and histone proteins. Because mental stress can alter the epigenetic status in neuronal cells, environmental factors may alter brain function through epigenetic changes. However, one advantage of epigenetic changes is their reversibility. Therefore, diseases due to abnormal epigenetic regulation are theoretically treatable. In fact, several drugs for treating mental diseases are known to have restoring effects on aberrant epigenetic statuses, and a novel therapeutic strategy targeting gene has been developed. In this review, we discuss epigenetic mechanisms of congenital and acquired neurodevelopmental disorders, drugs with epigenetic effects, novel therapeutic strategies for epigenetic diseases, and future perspectives in epigenetic medicine.
format Online
Article
Text
id pubmed-3763642
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-37636422013-11-14 Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders Kubota, Takeo Takae, Hirasawa Miyake, Kunio Pharmaceuticals (Basel) Review The number of children with mild neurodevelopmental disorders, such as autism, has been recently increasing in advanced countries. This increase is probably caused by environmental factors rather than genetic factors, because it is unlikely that genetic mutation rates suddenly increased within a short period. Epigenetics is a mechanism that regulates gene expression, depending not on the underlying DNA sequence but on the chemical modifications of DNA and histone proteins. Because mental stress can alter the epigenetic status in neuronal cells, environmental factors may alter brain function through epigenetic changes. However, one advantage of epigenetic changes is their reversibility. Therefore, diseases due to abnormal epigenetic regulation are theoretically treatable. In fact, several drugs for treating mental diseases are known to have restoring effects on aberrant epigenetic statuses, and a novel therapeutic strategy targeting gene has been developed. In this review, we discuss epigenetic mechanisms of congenital and acquired neurodevelopmental disorders, drugs with epigenetic effects, novel therapeutic strategies for epigenetic diseases, and future perspectives in epigenetic medicine. MDPI 2012-04-05 /pmc/articles/PMC3763642/ /pubmed/24281407 http://dx.doi.org/10.3390/ph5040369 Text en © 2012 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Kubota, Takeo
Takae, Hirasawa
Miyake, Kunio
Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders
title Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders
title_full Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders
title_fullStr Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders
title_full_unstemmed Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders
title_short Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders
title_sort epigenetic mechanisms and therapeutic perspectives for neurodevelopmental disorders
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763642/
https://www.ncbi.nlm.nih.gov/pubmed/24281407
http://dx.doi.org/10.3390/ph5040369
work_keys_str_mv AT kubotatakeo epigeneticmechanismsandtherapeuticperspectivesforneurodevelopmentaldisorders
AT takaehirasawa epigeneticmechanismsandtherapeuticperspectivesforneurodevelopmentaldisorders
AT miyakekunio epigeneticmechanismsandtherapeuticperspectivesforneurodevelopmentaldisorders